Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma
Sign Up to like & getrecommendations! Published in 2020 at "Respiratory Medicine"
DOI: 10.1016/j.rmed.2020.105991
Abstract: Abstract Background Currently, five biologic treatment options are available for use in patients with uncontrolled persistent asthma: three interleukin (IL)-5 antagonists, which either bind to the anti-IL-5 ligand (mepolizumab, reslizumab) or to the IL-5 receptor… read more here.
Keywords: patients uncontrolled; treatment; anti; uncontrolled persistent ... See more keywords